Stockreport

Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies [Yahoo! Finance]

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF Paris (France), 17 October, 2024 – Iktos, a leader in Artificial Intelligence (AI) and Robotics, is revolutionizing drug discovery by addressing inefficiencies in tradi [Read more]